Nobel laureate David Baker’s latest foundation model can design proteins that interact to any biomolecule for broad biotech applications.

That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...

It was thought that complex cells couldn’t survive above a certain temperature, but a tiny amoeba has proven that assumption ...

Researchers from the Cluster of Excellence Balance of the Microverse at the University of Jena and the Leibniz-HKI, together with international partners, have uncovered a mechanism that determines how ...

Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...

This paper aims to critique the argument constructed by Anna Smajdor and Joona Räsänen that pregnancy is a disease. Their argument that pregnancy fits the features of disease they enumerate stems from ...

A tiny amoeba has broken a pretty big record. The newly discovered species of single-celled organism can divide and reproduce ...

The mammalian elongation complex has remained a mystery – until researchers discovered how it controls its speed.

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

To understand how CBD may reduce pain, it’s important to learn the basics of the endocannabinoid system (ECS), a complex ...

As researchers delve deeper into the science of the oral microbiome, preventive dental care is being redefined.